论文部分内容阅读
目的:研究阿希米在宫颈糜烂中的临床应用价值与安全性。方法:选取我院在2013年5月至2014年5月间收治的102例宫颈糜烂患者的临床资料,以抽签的形式,将患者分为两组,其中单号为对照组,双号为观察组,每组各51例病例。观察组采用阿希米治疗,对照组采用激光治疗,均于治疗1个月后,比较两组患者的临床疗效。结果:观察组中有26例患者治愈,13例患者治疗显效,10例患者治疗有效,总有效率为96.1%;观察组中有12例患者治愈,15例患者治疗显效,18例患者治疗有效,总有效率为88.2%。两组患者在治疗效果上对比差异不大,无统计学意义(P>0.05)。观察组无患者出现明显不良反应,对照组中有14例(27.5%)患者出现出血症状,其中12例患者轻微出血,2例患者出血较为严重。两组患者在不良反应率上对比具有统计学意义(P<0.05)。结论:阿希米在宫颈糜烂疾病的治疗中有着较高的临床应用价值,有利于促进患者疾病症状的改善,值得临床推广应用。
Objective: To study the clinical value and safety of acephate in cervical erosion. Methods: The clinical data of 102 patients with cervical erosion treated in our hospital from May 2013 to May 2014 were selected. The patients were divided into two groups by lottery, the single number was control group, the double number was observation Group, each of 51 cases. The observation group was treated with Asimi, while the control group was treated with laser. After one month of treatment, the clinical efficacy was compared between the two groups. Results: In the observation group, 26 patients were cured, 13 patients were cured, 10 patients were treated effectively, the total effective rate was 96.1%. In the observation group, 12 patients were cured, 15 patients were cured, 18 patients were effective , The total effective rate was 88.2%. The two groups of patients in the treatment effect was no significant difference, no statistically significant (P> 0.05). No adverse reactions were observed in the observation group. Bleeding symptoms were found in 14 patients (27.5%) in the control group, of which 12 patients had mild bleeding and 2 patients had severe bleeding. The two groups of patients in the adverse reaction rate was statistically significant (P <0.05). Conclusion: Asimi has a high clinical value in the treatment of cervical erosion diseases, which is helpful to improve the symptoms of patients with diseases and is worthy of clinical application.